We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
Gone for 312 days. Could come back at any time — we're watching for you.
Out of stock 312 days · last price £795
The 2021-2026 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)
One email. No newsletter. No nudges.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 657 days · 657 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 657 days • 1 price levels
Price Analysis
Most common price: £795 (657 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 657 days
Product Specifications
- Format
- paperback
- ASIN
- B082JP3WQP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 13 February 2020
- Listed Since
- 13 December 2019
Similar Products You Might Like
The 2021-2026 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
Price unavailable
Esophageal Cancer: Epidemiology, Diagnosis and Treatment
Brand: Nova Science Publishers
Esophageal Cancer: Prevention, Diagnosis and Therapy
Price unavailable
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
Price unavailable
Esophageal Cancer - Cell and Molecular Biology, Biomarkers, Nutrition and Treatment
IntechOpen
Esophageal Cancer: Prevention, Diagnosis and Therapy
Springer
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
Esophageal Cancer, An Issue of Thoracic Surgery Clinics (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)
Elsevier
The 2025-2030 World Outlook for Esophagus-Targeting Smart Pills
Price unavailable
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean
Esophageal Cancer: Diagnosis and Treatment
Springer
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
Esophageal Cancer and Beyond
IntechOpen
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Japan
The 2025-2030 World Outlook for Carcinoembryonic Antigen
Price unavailable
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
Price unavailable
Risk Factors and Therapy of Esophagus Cancer
Springer
Risk Factors and Therapy of Esophagus Cancer
Springer
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2023-2028 World Outlook for Carcinoembryonic Antigen
